Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus

Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death

(2013) Natalia V. Kirienko et al.   Cell Host & Microbe

An integrated microfluidic platform for evaluating in vivo antimicrobial activity of natural compounds using a whole-animal infection model

(2013) Jianping Yang et al.   LAB ON A CHIP

Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes

(2012) T. Suzuki et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibacterial and Synergy of Berberines with Antibacterial Agents against Clinical Multi-Drug Resistant Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA)

(2012) Guo-Ying Zuo et al.   MOLECULES

Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids

(2012) S. Brown et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: A case report

(2012) Kavitha Saravu et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Community-associated and healthcare-associated methicillin-resistantStaphylococcus aureusvirulence towardCaenorhabditis eleganscompared

(2012) Shandra R. Day et al.   Virulence

Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software

(2011) Lee Kamentsky et al.   BIOINFORMATICS

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Challenges of Antibacterial Discovery

(2011) L. L. Silver   CLINICAL MICROBIOLOGY REVIEWS

Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses inStaphylococcus aureus

(2010) Jennifer Campbell et al.   ACS Chemical Biology

Repositioning of an existing drug for the neglected tropical disease Onchocerciasis

(2010) Christian Gloeckner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Distinct Pathogenesis and Host Responses during Infection of C. elegans by P. aeruginosa and S. aureus

(2010) Javier E. Irazoqui et al.   PLoS Pathogens

High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model

(2009) Terence I. Moy et al.   ACS Chemical Biology

Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices

(2009) James H. Jorgensen et al.   CLINICAL INFECTIOUS DISEASES

Minocycline—an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii

(2009) Eliahu Bishburg et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Genomic variation and evolution of Staphylococcus aureus

(2009) Jodi A. Lindsay   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Epidemiology of Methicillin‐ResistantStaphylococcus aureus

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany

(2008) Veronica Alba et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS